Atlas Trials

Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691

Clinical trial NCT00810758 · COMPLETED

Trial details

NCT number
NCT00810758
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C Virus
Start date
2009-01-01
Primary completion
2009-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.